organ growth acceler strong
ebitda margin tow
restrict cs advis acquisit lhx secur
detect busi therefor rate target price
comment pend transact
result report result revenu y/i
organ vs con adjust ep vs
con adj ebitda y/i vs con adj ebitda
margin increas y/i result full year
impli guidanc book-to-bil ttm basi
backlog grew y/i record
guidanc introd guidanc call revenu
midpoint vs messi con adj ebitda margin adjust
ep vs con management revenu guid contempl organ
growth revenu dynet prorat close date jan
management target ocf higher vs con capital-expenditure
impli vs con mgmt ocf target emb support
implement receiv monet program benefit
partial off-set revers advanc payment guidanc
contempl impact ldoss acquisit lhx secur detect
call highlight recent mega-win benefit book due protest
idiq contract structur protest resolv task order receiv benefit
book follow guidanc emb minim level contribut ngen
due risk protest capit deploy initi pivot toward debt
reduct rather share repurchas leverag declin capital-expenditure
normal revenu beyond management expect move margin
expect upward time deliv accret recent deal continu
execut core busi
estim ep est rise intro estimate
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
chang work capit
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ activ
effect exchang rate
chang net cash/debt
net debt start
chang net debt
net debt end
intang asset goodwil
total liabil equiti
share wtd average
price book
roe stated-return
net debt ebitda
 close
defens solut revenu increas y/i driven new
award net increas volum partial off-set complet certain contract
adjust opm increas y/i attribut new award releas
contract reserv favor mix higher net profit write-up
civil revenu increas y/i organ driven
increas volum new award partial off-set complet certain contract
divestitur commerci cybersecur busi adjust opm increas
bp y/i primarili driven profit write-up new award favor
revenu increas y/i organ driven
increas program volum new award acquisit off-set
complet contract divestitur health staff augment busi
adjust opm essenti flat y/i
figur backlog sale
 sale lh total backlog lh total backlog ttm sale midpointadjust ebitda dilut bp midpointcash cont feb vs charl martineau pm univers toronto februari
changeperiod interseg eliminations- total defens oper margin adjust oper marginsdefens adjust oper ebitda bpsinterest incom rate incom continu incom attribut net incom attribut per share share net consensusv prior yearv prior charl martineau pm univers toronto februari
compani mention price
robert spingarn certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
